Page 1260 - Cote clinical veterinary advisor dogs and cats 4th
P. 1260

Mass, Splenic   631


                                                ○   Diffuse splenomegaly associated with   24 hours) and typically resolve after 1-5
                                                  immune-mediated disorders, may/may   •  Long-term follow-up depends on diagnosis
                                                                                      days.
  VetBooks.ir                                   ○   Splenectomy is contraindicated in cases   (e.g.,  thoracic  radiographs  q  3  months  to   Diseases and   Disorders
                                                  not help underlying disease process
                                                                                    monitor for pulmonary metastasis)
                                                  of babesiosis and other hematologic
                                                  infections.
                                                                                   PROGNOSIS & OUTCOME
                                               Chronic Treatment
                                               •  Supportive care in the postoperative period  •  Prognosis  varies  with  cause  for  malignant
                                                ○   Analgesia                       and nonmalignant causes of splenic mass.
                                                ○   Fluid therapy must replace blood volume   •  Hemangiosarcoma (most common malignant
                                                  that was present in the mass.     splenic neoplasm in dogs); median survival
           SPLENIC MASS  The large splenic mass was removed   ○   Transfusion therapy (p. 1169)
           and diagnosed as benign nodular hyperplasia. Size                        time: 0-3 months with surgery alone, 4-8
           and shape of the mass are not a substitute for   ○   Treatment of cardiac arrhythmias (pp.   months with surgery and chemotherapy
           histopathologic diagnosis.             1033 and 1457)                  •  Cats with systemic mastocytosis that undergo
                                               •  Adjunct  chemotherapy  for  malignant   splenectomy often have extended survival
                                                neoplasia                           times and may be cured.
                                                                                  •  Prognostic indicators: NOTE: these findings
             shock with IV fluids and blood products as   Drug Interactions         are suspicious for but do not confirm a
             needed. Immediate surgery is indicated for   •  Avoid acepromazine or other phenothiazine   diagnosis. Only histopathologic evaluation of
             patients with active hemorrhage if pressures   tranquilizers before surgery.  tissue can definitively differentiate malignant
             cannot be stabilized or if blood products are   ○   Causes splenic enlargement; may worsen   and benign disease.
             not available.                       bleeding and complicate removal   ○   Preoperatively, dogs with anemia, nucle-
           •  Some causes of splenic mass are amenable to   ○   Can cause hypotension through central   ated RBCs, abnormal RBC morphology,
             medical treatment (e.g., lymphoma, diffuse   mechanisms and through alpha-adrenergic   or splenic rupture are more likely to have
             splenomegaly associated with congestion from   actions;  may  progress  to  cardiovascular   malignant splenic neoplasia.
             right heart failure or from infectious [e.g.,   collapse               ○   In one study, 50% of large incidentally
             babesiosis, cytauxzoonosis] or inflammatory   •  Avoid phenylephrine unless splenic mass is   discovered splenic masses in the absence
             disease [e.g., immune-mediated hemolytic   confirmed benign              of hemoabdomen were benign.
             anemia]).                          ○   Risk of seeding of tumor cells
                                                                                   PEARLS & CONSIDERATIONS
           Acute General Treatment             Possible Complications
           •  Initial stabilization for acute intraabdominal   •  Rupture of splenic mass  Comments
             hemorrhage                         ○   Hemoabdomen                   •  In  the  dog,  a  splenic  mass  may  be  non-
             ○   IV  fluid  resuscitation  (crystalloids  ±   ○   Hypotension       neoplastic (e.g., hematoma) or may be a
               colloids)                        ○   Hemorrhagic/hypovolemic shock   benign (e.g., hemangioma) or malignant
             ○   Blood product transfusion if needed    ○   Coagulation disorders   (e.g., hemangiosarcoma) neoplasm, and the
               (p. 1169)                        ○   Cardiovascular collapse and death  entire mass and/or spleen should always be
             ○   Definitive surgical therapy is recom-  •  Intraoperative and postoperative complica-  submitted for histopathologic exam.
               mended after patient is stabilized.  tions                         •  Be sure to section (bread-loaf) large masses
             ○   Immediate surgery if patient cannot be   ○   Hemorrhage            into slices < 1-2 cm thick to allow appropri-
               stabilized (i.e., massive, ongoing internal   ○   Ventricular arrhythmias  ate penetration of formalin.
               hemorrhage)                      ○   Damage to blood supply of pancreas  •  It  is  impossible  to  differentiate  splenic
           •  Treat coagulation disorders if prothrombin   ○   Pancreatitis from traumatic handling of   masses based on their gross appearance.
             time/activated partial thromboplastin time   pancreas                  Diagnosis is always based on histopathologi-
             (PT/aPTT) significantly prolonged (> 2 ×   ○   Chronic  anemia  from loss  of red    cal exam.
             normal) (p. 1325):                   blood cell reservoir and decreased hema-  •  Accelerated idioventricular rhythms do not
             ○   Fresh-frozen plasma, fresh whole blood  topoiesis                  require treatment; however, monitor closely
           •  Correct/control ventricular arrhythmias.  ○   Diminished immune function (especially   because they can convert to ventricular
             ○   Correction of anemia/hypovolemia or   vector-borne and fungal disease)  tachycardia.
               electrolyte abnormalities often resolves   ○   Portal vein thrombosis (uncommon)
               ventricular arrhythmias without antiar-  ○   Gastric  dilation/volvulus  (uncommon);   Technician Tips
               rhythmic drugs.                    consider gastropexy in predisposed breeds  •  The volume lost by removal of large masses
             ○   Treat if arrhythmia persists and is patho-                         frequently causes postoperative hypovolemia.
               logic (pp. 1033 and 1457).      Recommended Monitoring               Familiarity with the signs of hypovolemia is
           •  Complete  splenectomy  is  necessary  for   •  Standard postoperative patient monitoring  imperative for postoperative management.
             control of hemorrhage and definitive   •  Serial PCV and total protein (TP) to monitor   •  Be  able  to  recognize  accelerated  idioven-
             diagnosis by histology.            for hemorrhage                      tricular rhythm, R-on-T complexes and
             ○   Partial splenectomy is not recommended   •  Heart rate, blood pressure, and urine output   ventricular tachycardia to know when to
               for splenic masses.              to evaluate hydration status and restore   alert the clinician for treatment of ventricular
             ○   Consider liver biopsy ± lymph node biopsy   euvolemia              arrhythmias (pp. 1033 and 1457).
               for staging purposes.           •  ECG monitoring for cardiac arrhythmias
           •  Nonsurgically treated splenic masses  ○   Continuous  ECG  for  first  24  hours   Client Education
             ○   Some neoplasms (e.g., lymphoma) treated   postoperatively; spot checks thereafter   •  Bleeding splenic masses
               with chemotherapy                  if no arrhythmias noted and/or prior   ○   Two-thirds are malignant, and two-thirds
             ○   Diffuse metastatic disease (e.g., heman-  arrhythmias resolving      of those are hemangiosarcoma.
               giosarcoma, histiocytic sarcoma): owner   ○   Ventricular arrhythmias may develop in   •  Splenic masses may rupture and cause lethal
               may elect palliative treatment only.  first 3 days postoperatively (most within   intraabdominal hemorrhage.

                                                      www.ExpertConsult.com
   1255   1256   1257   1258   1259   1260   1261   1262   1263   1264   1265